Figure 3.
Forest plot for the meta-analysis of relative risk of hypertension (grade ≥3) with bevacizumab-treated patients.
Abbreviations: OR, odds ratio; M–H, Mantel–Haenszel; CI, confidence interval; PLA, placebo; PAC, paclitaxel; BEV, bevacizumab; TRE, trebananib; MOT, motesanib; DOC, docetaxel; anthra, anthracycline; CAP, capecitabine; TAX, taxanes.